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INTRODUCTION
O ver the past 3 decades, extensive research has investigated the potential of sodium bicarbonate (NaHCO 3 ) ingestion for inducing metabolic alkalosis and enhancing subsequent physical performance (see McNaughton and colleagues [18] for a recent review). Early research reported that NaHCO 3 loading was effective for improving the capacity for shortterm, high-intensity exercise (2, 17, 18) , whereas more recent studies have shown that NaHCO 3 also can enhance performance during aerobic endurance and prolonged, intermittent high-intensity exercise (3, 19, 23) .
The performance-enhancing effects of NaHCO 3 are associated largely with the degree of metabolic alkalosis (12) . The contemporary viewpoint is that, during highintensity exercise, the increased alkalosis attenuates the rate of increase in free protons (H + ) in the sarcoplasm, thereby reducing the competition on the ionizable binding sites of the actin/myosin complex, as well as delaying sarcoplasmic reticulum dysfunction with regard to Ca 2+ release and uptake (1, 7, 24) . This, in turn, is thought to delay the onset of fatigue during high-intensity exercise (1, 7, 22, 24) .
The degree of metabolic alkalosis is altered by the dosage and timing of NaHCO 3 ingestion. However, although much research has investigated the types of exercise that are enhanced with NaHCO 3 ingestion, to date, there has been limited research on the dosage and timing of NaHCO 3 ingestion that optimizes metabolic alkalosis and the associated ergogenic effects. This is important because doses between 0.2 and 0.3 gÁkg 21 have commonly resulted in equivocal performance findings (9, 11, 15, 18, 26) . For example, Horswill et al. (10) reported that dosages of 0.2 gÁkg 21 or less were ineffective for improving sprint performance, whereas McNaughton (17) reported that, with dosages of 0.1, 0.2, 0.3, 0.4, and 0.5 gÁkg sprint performance. Dosages of 0.15 and 0.20 gÁkg 21 have also been reported by others to enhance performance (5, 13) .
In previous studies, the time between NaHCO 3 ingestion and exercise onset has ranged from 1 to 2 hours. However, the rationale for using any particular time period is typically not given but instead appears to have been arbitrarily chosen. A limitation to this approach is that the time course of the level of metabolic alkalosis may differ between various dosages, and therefore, the ergogenic effect of NaHCO 3 may be moderated by the interaction of the dosage with the timing of ingestion before exercise onset. Establishing the level and time course of alkalosis obtained from different NaHCO 3 loading protocols would establish the relative efficacy of each protocol for eliciting alkalosis and rationalize the timing of ingestion before exercise onset. Two recent studies investigated the time course of metabolic alkalosis and reported that peak alkalosis occurred between 60 and 90 minutes postingestion (20, 21) . However, these studies used only a 0.3 gÁkg 21 dosage, so the time course and relative alkalosis elicited by other dosages was not established.
The purpose of this study was to determine the bloodbuffering profile of various NaHCO 3 loading protocols. The efficacy of the various loading protocols was assessed by the level of blood alkalosis. We hypothesized that the level and timing of peak alkalosis would be different for the various loading protocols.
METHODS

Experimental Approach to the Problem
The study was separated into 2 parts. In Part A, measures were made of blood alkalosis throughout 120 minutes after the ingestion of various single NaHCO 3 dosages (0.3 was substituted for NaHCO 3 . These ingestion protocols have been the most commonly used in previous research (18) .
Subjects
Eight male volunteers with the following mean 6 SD characteristics completed all aspects of the investigation: age, 22.4 6 5.7 years; height, 179.8 6 9.6 cm, body mass, 76.3 6 14.1 kg. All subjects provided written informed consent in accordance with the departmental and university ethical procedures and following the principles outlined in the Declaration of Helsinki. None of the subjects included in the study were currently taking any nutritional supplements or on any prescription medication. Before the first laboratory visit, subjects were instructed as to the importance of nutritional intake and asked to control, record, and duplicate their food intake for all trials (collected and reviewed but not presented). In addition, all subjects were told to avoid spicy foods and excessive intake of meat protein as well as consume 500 mL of water during each meal preceding a trial.
Procedures
Part A. . Upon arrival to the initial trial, a baseline capillary blood sample was obtained. Thereafter, the subjects ingested their prescribed solution over a 10-minute period. Once consumed, a timer was started, and the subjects then rested calmly for 120 minutes. Capillary blood samples were obtained every 20 minutes for 120 minutes.
Part B. The 3 remaining trials followed the same pretest diet guidelines, sampling, and measurement procedures as Part A. The ingestion protocols were as follows: a) a single 0.3 gÁkg NaHCO 3 dosage was diluted into 500 mL of a low-calorie, flavored cordial and consumed over a 10-minute period. In each loading protocol, subjects were required to report back to the laboratory for capillary blood sampling at 11:00, 13:00, 15:00, and 17:00 hours.
Blood Sampling and Analysis
All blood samples were obtained aseptically by way of capillary finger sticks. The hand was heated for 10 minutes before all draws using a heating pad wrapped on the forearm. This was implemented to increase blood flow and arterialize capillary blood at the sampling site. Whole blood was collected in a balanced heparin 200 mL blood gas capillary tube for immediate analysis of pH, bicarbonate (HCO 3 2 ), and base excess (BE). The sample was immediately capped and placed on ice until subsequent (always within 5 min of collection) blood gas and acid-base analyses using a clinical blood gas analyzer (OMNI 4 Blood Gas Analyzer, Roche Diagnostics, Ltd., Sussex, UK). All measures were done in duplicate, and the range of intraclass correlation coefficients were 0.81 to 0.95, p , 0.01, for all dependent variables, respectively.
Statistical Analyses
Statistical analyses were completed using SPSS for Windows software (release 16.0; SPSS, Inc., Chicago, IL, USA). The required sample size of 8 subjects was determined by prospective statistical power analysis using PASS 2008 software (NCSS, LLC, Kaysville, UT, USA), with alpha and beta set at , BE) profiles were analyzed using two-way (condition 3 time) analysis of variance (ANOVA) for repeated measures. A Huynh-Feldt correction was applied when Mauchly's test indicated that the sphericity assumption for any particular within-subjects effect was not plausible. One-way ANOVA for repeated measures were used to analyze differences in baseline values (pre-ingestion) between conditions for all variables. Sidak-adjusted post hoc tests were used for pairwise comparisons where there was a significant F ratio for any particular within-subject effect. Two-tailed statistical significance was accepted as p , 0.05.
RESULTS
Part A
Mean (SD) blood acid-base data are presented in Table 1 3 2 (F = 6.6; p , 0.001) and BE (F = 6.9; p , 0.001) but not pH (F = 1.8; p = 0.13). The HCO 3 2 concentration at 60 minutes was significantly higher than at 100 minutes (p = 0.024) and 120 minutes (p = 0.023). The BE was significantly higher at 60 minutes (p = 0.008) and 100 minutes (p = 0.039) than at 120 minutes. There were also significant condition x time interaction effects for pH Table 1 for significant differences between conditions at specific time points).
Part B
Mean (SD) blood acid-base data are presented in Table 2 . There were significant main effects for condition for pH (F = 6.2; p = 0.029), HCO 3 2 (F = 107.8; p , 0.001), and BE (F = 81.6; p , 0.001). The mean value for the SMD condition was significantly higher than for the SED and CED conditions for each of the 3 variables (p , 0.05). There were also significant ) and base excess (BE) at 11:00, 13:00, 15:00 and 17:00 hrs for the alternative sodium bicarbonate loading protocols. Like superscript letters for any given variable indicate that the difference between conditions is statistically significant (p , main effects for time for pH (F = 4.8; p = 0.011), HCO 3 2 (F = 4.8; p = 0.011), and BE (F = 5.7; p = 0.005). The HCO 3 2 and BE were significantly lower at 17:00 hours than at 11:00 hours (both p = 0.007). Post hoc tests for time were all nonsignificant for pH (p $ 0.12). There was a significant condition x time interaction effect for HCO 3 2 (F = 5.9; p , 0.001) and BE (F = 6.5; p , 0.001), but the interaction term for pH did not quite reach statistical significance (F = 2.4; p = 0.060) (see Table 2 for significant differences between conditions at specific time points).
DISCUSSION
A main finding of this study was that throughout 2 hours after ingestion of a single bolus of either 0. Figures 1 and 2) .
The time-to-peak blood buffering for the 0.3 gÁkg 21 dosage found in this study is similar to the 60 to 90 minutes reported by 2 recent studies (20, 21) . However, the time-to-peak observed in the 0.2 gÁkg 21 trial occurred markedly earlier (approximately 40-50 min) than the higher load (Table 1) . Highlighting this difference is important because there have been numerous studies that have incorporated the 0.2 gÁkg 21 dose into their methodologic application yet have also begun the exercise trial at 60 minutes or longer (5, 10, 17) . This discrepancy between time-to-peak of the 2 loads and the start of exercise may explain some of the equivocal findings with regard to the efficacy of NaHCO 3 loading (12). Our findings would suggest that to maximize the ergogenic potential of 0.2 gÁkg 21 NaHCO 3 , exercise should begin no later than 50 minutes postingestion.
Although single boluses of 0.3 gÁkg 21 NaHCO 3 ingested 1 to 2 hours before exercise have been the most commonly reported loading protocols in experimental research, several recent studies have used variations of this protocol in attempts to further increase the ergogenic potential. Bishop and Claudius (3) implemented a ''stacking'' protocol, whereby the overall NaHCO 3 load remained 0.3 gÁkg 21 or greater but was split into smaller dosages (0.2 gÁkg 21 ingested at time 0 and again 70 min post initial ingestion, with exercise starting at 90 min postingestion). This loading sequence assumes that there is a stacking effect associated with NaHCO 3 ingestion. Interestingly, the HCO 3 2 and BE profiles of the 0.2 gÁkg 21 in the current study exhibited a plateau at approximately 70 minutes (approximately 29 mmolÁL 21 ) and remained so for the final 50-minute profile (Table 1, Figures 1 and 2) . Whether the extracellular milieu has reached some sort of homeostatic buffering level at this time point remains debatable, but it is plausible that this plateau may justify the concept of stacking NaHCO 3 loads.
Two other studies have incorporated the stacking concept, yet, instead of hours before exercise, they involved multiple days of NaHCO 3 loading before assessing exercise performance (6, 14) . Alternative NaHCO 3 ingestion protocols are attractive because they could combine both an increased blood buffering capacity and a reduction in the negative side effects associated with bolus ingestions ($0.3 gÁkg 21 NaHCO 3 ). In Part B of the present study, we replicated some of the alternative loading sequences used in previous research to investigate their time course for blood buffering. The SMD condition resulted in significantly higher blood buffering than the SED and CED conditions, with the HCO 3 2 and BE concentrations remaining significantly elevated until 13:00 hours (equivalent to 4 hr postingestion) (Figures 3 and 4) . Interestingly, the sustained HCO 3 2 elevation observed up to 4 hours postingestion was similar to those levels elicited by the 0.2 and 0.3 gÁkg 21 dosages at 120 minutes in Part A. This would further suggest that stacking the loading sequence may be an effective practice for up to 4 hours post initial ingestion. This has important practical implications not only in terms of enhancing extracellular blood-buffering potential but may also prove more tolerable for those individuals either unfamiliar with the practice of NaHCO 3 loading or those susceptible to gastrointestinal (GI) distress.
The SED and CED loading results are in contrast with those reported elsewhere using a similar multiday loading protocol. Douroudos and colleagues (6) . Methodologic discrepancies may explain some of the differences. For example, it is unclear as to whether arterial or venous blood samples were used in the Douroudos et al. study (6) . Regardless, the relatively low metabolic alkalosis in both the SED and CED conditions in our study indicate there is little ergogenic benefit from ingesting NaHCO 3 the day before (or several days before) and that NaHCO 3 should be ingested on the same day as the exercise is being undertaken.
PRACTICAL APPLICATIONS
Our findings suggest that single boluses of either 0.2 or 0.3 gÁkg 21 NaHCO 3 result in similar buffering effects, but the 0.3 gÁkg 21 dosage should be ingested approximately 60 minutes before exercise, and the 0.2 gÁkg 21 dosage should be ingested between 40 and 50 minutes before exercise. These recommendations are based on the premise that the ergogenic potential of NaHCO 3 is associated with the degree of metabolic alkalosis (12) . A NaHCO 3 dosage of 0.1 gÁkg 21 cannot be recommended because the blood HCO 3 2 concentration was, on average, 7.0% lower than the 0.2 gÁkg 21 dosage and 9.8% lower than the 0.3 gÁkg 21 dosage. This is consistent with the lack of ergogenic effect reported by McNaughton (17) for a single bolus of 0.1 gÁkg 21 NaHCO 3 . In addition, if a stacking approach is implemented using 0.3 gÁkg 21 of NaHCO 3 , then the loading should be separated by approximately 90 minutes to allow for the initial bolus load to plateau (Table 1) . Conversely, if stacking with 0.2 gÁkg 21 , then we would recommend the second dose at approximately 70 minutes post initial ingestion. It must be stressed that no research has been published using more than 2 NaHCO 3 loading sequences in 1 day, and we are not advocating loading above this volume because of potentially dangerous and harmful side-effects (i.e., muscle weakness, muscle spasms, convulsions, or seizures). Because the use of NaHCO 3 loading as a supplement appears widespread (4, 8, 25) , we also recommend that athletes generally should not ingest single NaHCO 3 dosages greater than 0.3 gÁkg 21 because these are associated with an appreciable increase in the incidence of other, less-harmful negative side-effects (17) . In terms of athletic performance, we also recommend that athletes experiment with their tolerance to different dosages because higher dosages are more likely to elicit acute symptoms of GI distress, bloating, or diarrhea (14) . In the current study, only 3 of the subjects reported GI discomfort (e.g., bloating) within the first 30 minutes of the 0.3 gÁkg 21 acute load (Part A), but these were only minimal and subsided after 45 minutes. The GI distress issue is very relevant in terms of the performance potential, but with doses at 0.3 gÁkg 21 or below, others have reported very little to no GI problems (17) . Another issue concerning NaHCO 3 loading strategies is that of the potential for dehydration. Because it is widely recognized that dehydration can have a negative impact on performance and because the standard NaHCO 3 supplementation protocol is equivalent to approximately 18 to 25 g, there is potential for inducing an osmotic gradient in the stomach and small intestines and consequently a loss of intracellular H 2 O. Thus, we would recommend monitoring hydration (ideally by plasma/urine osmolality or urine-specific gravity) before and during any loading sequence, especially during prolonged exercise or during exposure to environmental stress (e.g., heat). This will provide valuable information in terms of the necessary fluid intake to maintain athletes' respective hydration status before exercise. Finally, athletes should be advised to ingest the NaHCO 3 on the same day as the exercise is being performed and that multiday NaHCO 3 loading protocols do not provide any additional buffering potential.
